awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38297507-B4E28AF2-71DB-419D-A252-7D6400C64356
Q38297507-B4E28AF2-71DB-419D-A252-7D6400C64356
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38297507-B4E28AF2-71DB-419D-A252-7D6400C64356
Targeting novel signaling pathways for resistant acute myeloid leukemia.
P2860
Q38297507-B4E28AF2-71DB-419D-A252-7D6400C64356
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38297507-B4E28AF2-71DB-419D-A252-7D6400C64356
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c322157fc117278b05572eae1e5da3cb0a327d48
P2860
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.